MKRN1 and metabolic syndrome: Consequently, MKRN1-null mice exhibit AMPK hyperactivity in liver and adipose tissue and are protected against diet-induced metabolic syndrome, whereas lowering MKRN1 expression in obese mice reversed non-alcoholic fatty liver disease.